Marks, J. R., Zhang, D., Hardman, T., Chen, Y., Hall, A., Simpson, L., . . . Hwang, E. S. (2025). Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance). Breast Cancer Research, 27(1), 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Marks, Jeffrey R., et al. "Genomic Alterations Are Associated with Response to Aromatase Inhibitor Therapy for ER-positive Postmenopausal Ductal Carcinoma in Situ: (CALGB 40903, Alliance)."
Breast Cancer Research 27, no. 1 (2025): 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Marks, Jeffrey R., et al. "Genomic Alterations Are Associated with Response to Aromatase Inhibitor Therapy for ER-positive Postmenopausal Ductal Carcinoma in Situ: (CALGB 40903, Alliance)."
Breast Cancer Research, vol. 27, no. 1, 2025, pp. 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.